Robert Charles Swanton
CIK: 0002079922
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BICYCLE THERAPEUTICS PLC
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct3.4K shares at avg. $3.47$12K - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct3.7K shares- - Oct 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
Sale(S)Direct102 shares at avg. $8.55$872.1 - Aug 12, 2025BCYC
BICYCLE THERAPEUTICS PLC
Award(A)Direct12.5K shares-
1-4 of 4 transactions
About Swanton Robert Charles
Swanton Robert Charles (SEC CIK 0002079922) files insider reports with the SEC as Director of BICYCLE THERAPEUTICS PLC (BCYC).
Signal8 holds 5 ownership filings by Swanton Robert Charles (1 Form 3, 4 Form 4), filed between Aug 14, 2025 and Oct 6, 2026. Those filings report 4 transactions, from Aug 12, 2025 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Swanton Robert Charles's filings is in CAMBRIDGE.
Recent filings by Swanton Robert Charles
Other insiders filing for BICYCLE THERAPEUTICS PLC (BCYC)
- Perry Jennifer Scott, Chief Operating Officer
- Skynner Michael, CHIEF SCIENTIFIC OFFICER
- Hannay Michael Charles Ferguson, CHIEF PROD & SUPPLY CHAIN OFF
- Lee Kevin, CHIEF EXECUTIVE OFFICER
- Thompson Travis Alvin, Chief Financial Officer
- Milnes Alistair, CHIEF OPERATING OFFICER